University of Chicago - Pharmaceuticals & Healthcare - Deals and Alliances Profile
October 2018
48
About the Report
About the Report
Summary
University of Chicago (UOC) is an academic and research university that offers education and research in various disciplines. The university offers undergraduate, master's and PhD programs in the areas of anthropology, art history, astronomy and astrophysics, biochemistry and molecular biology, biophysical sciences, business, cancer biology, chemistry, classics, comparative human development, statistics, religious studies, sociology, comparative literature, computational neuroscience and computer science, among others. It offers medical studies through Pritzker School of medicine. The university operates institutes and research centers in France, the US, China, India, Hong Kong and Bangladesh. UOC is headquartered in Chicago, Illinois, the US.
University of Chicago-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
University of Chicago, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
University of Chicago, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
University of Chicago, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
University of Chicago, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
University of Chicago, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
University of Chicago, Medical Devices Deals, 2012 to YTD 2018 10
University of Chicago, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
University of Chicago, Pharmaceuticals & Healthcare, Deal Details 13
Partnerships 13
Trident Brands Enters into Research Agreement with NorthShore University HealthSystem 13
Eisai Enters into Research Agreement with Broad Institute, Colorado State University and University of Chicago 14
twoXAR Enters into Research Agreement with University of Chicago Department of Medicine 15
AbbVie Enters into Research Agreement with University of Chicago 16
Takeda Pharma Enters into Research Agreement with University of Chicago and Icahn School of Medicine at Mount Sinai 17
Evelo Therapeutics Partners with University of Chicago 18
Celgene Partners with Recombinant Antibody Network 19
Life Technologies Enters Into Joint Venture Agreement With Structural Genomics Consortium 20
Merger 21
Advocate Health Care to Merge with NorthShore University Health System 21
Licensing Agreements 22
Aridis Pharma Enters into Licensing Agreement with University of Chicago 22
Evelo Biosciences Enters into Licensing Agreement with University of Chicago 23
RiMO Therapeutics Enters into Licensing Agreement with University of Chicago 24
Corcept Therapeutics Enters into Licensing Agreement with University of Chicago 25
University of Chicago-Key Competitors 26
University of Chicago-Key Employees 27
University of Chicago-Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 30
Government and Public Interest 30
Jun 13, 2018: Cryo-EM reveals interaction between major drug targets 30
May 07, 2018: Debbie's Dream Foundation: Curing Stomach Cancer Raises More Than USD 300,000 for Stomach Cancer Research 32
May 07, 2018: Ludwig study confirms curable state between localized and systemic cancers 33
Apr 16, 2018: Relypsa Funds Three Innovative Research Projects on Hyperkalemia and Associated Disorders 34
Nov 17, 2017: Researchers receive USD 500,000 grant to study the microbiome of death 35
Nov 15, 2017: Wider sampling of tumor tissues may guide drug choice, improve outcomes 36
Nov 08, 2017: Novel approach could limit common complications of immunotherapy 38
Oct 19, 2017: Merck Foundation Launches Five-Year Initiative to Improve Diabetes Care for Vulnerable and Underserved U.S. Communities 39
Oct 18, 2017: Globus expands data services to accelerate secure cancer research 40
Sep 27, 2017: UChicago's Ci3 receives NIH grant to increase access to HIV prevention medication in community pharmacies 41
Aug 24, 2017: Novel RNA Discoveries Could Improve Stem Cell Research 42
Product News 44
Jun 22, 2018: Research team discovers drug compound that stops cancer cells from spreading 44
Feb 19, 2018: Researchers invent tiny, light-powered wires to modulate brain's electrical signals 46
Other Significant Developments 47
Aug 30, 2018: Blocking cellular pathway may make radiotherapy more effective by activating immune system, early study reports 47
Appendix 48
Methodology 48
About GlobalData 48
Contact Us 48
Disclaimer 48
List of Figure
List of Figures
University of Chicago, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
University of Chicago, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
University of Chicago, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
University of Chicago, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
University of Chicago, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
University of Chicago, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
University of Chicago, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
University of Chicago, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
University of Chicago, Medical Devices Deals, 2012 to YTD 2018 10
List of Table
List of Tables
University of Chicago, Pharmaceuticals & Healthcare, Key Facts 2
University of Chicago, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
University of Chicago, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
University of Chicago, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
University of Chicago, Deals By Therapy Area, 2012 to YTD 2018 9
University of Chicago, Medical Devices Deals, 2012 to YTD 2018 10
University of Chicago, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Trident Brands Enters into Research Agreement with NorthShore University HealthSystem 13
Eisai Enters into Research Agreement with Broad Institute, Colorado State University and University of Chicago 14
twoXAR Enters into Research Agreement with University of Chicago Department of Medicine 15
AbbVie Enters into Research Agreement with University of Chicago 16
Takeda Pharma Enters into Research Agreement with University of Chicago and Icahn School of Medicine at Mount Sinai 17
Evelo Therapeutics Partners with University of Chicago 18
Celgene Partners with Recombinant Antibody Network 19
Life Technologies Enters Into Joint Venture Agreement With Structural Genomics Consortium 20
Advocate Health Care to Merge with NorthShore University Health System 21
Aridis Pharma Enters into Licensing Agreement with University of Chicago 22
Evelo Biosciences Enters into Licensing Agreement with University of Chicago 23
RiMO Therapeutics Enters into Licensing Agreement with University of Chicago 24
Corcept Therapeutics Enters into Licensing Agreement with University of Chicago 25
University of Chicago, Key Competitors 26
University of Chicago, Key Employees 27
University of Chicago, Subsidiaries 28
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.